HIGHLIGHTS
- who: Jiaqi Liang et al. from the United States Kazan Federal University, Russia have published the paper: Serum soluble DR5 predicts mortality risk in patients with HBV-related hepatocellular carcinoma, in the Journal: (JOURNAL)
- what: This is the first finding that the serum sDR5 is an independent prognostic factor for 2-year overall survival in patients with HBV-HCC.
- how: In the derivation cohort the baseline characteristics of patients in the survival and non-survival groups were compared and the results showed that in addition to age sex smoking alcohol consumption family history . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.